What Is The Long-term Outlook for AMC Stock?
Meme stock extraordinaire AMC Entertainment Holdings, Inc. (NYSE:AMC) has long…
Buy
75
KYMR Quote, Financials, Valuation and Earnings
Last price:
$46.43
Seasonality move
:
30.84%
Day range:
$44.62 - $46.82
52-week range:
$19.45 - $53.27
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
61.95x
P/B ratio:
3.90x
Volume:
570.1K
Avg. volume:
956.5K
1-year change:
49.18%
Market cap:
$3.1B
Revenue:
$47.1M
EPS (TTM):
-$3.10
KYMR Analysts' Consensus Rating
The 16 analysts providing 12-month price projections for Kymera Therapeutics shares anticipate an average target of $62.32, ranging from a low estimate of $51.00 to a high estimate of $97.00. This average target implies a growth of 32.19% compared to the current stock price of $47.14.
Consensus Price Target
$62.32
Highest Price Target
$97.00
Lowest Price Target
$51.00
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 13 | 13 | 16 |
| Hold | 4 | 3 | 0 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
KYMR Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NuScale the Best Nuclear Stock to Buy?
NuScale Power (NYSE:SMR) is a nuclear power startup that has…
Where Will Kestra Medical Stock Be in 1 Year?
Kestra Medical Technologies (NASDAQ:KMTS) is a medical device startup that…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 42x
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 50x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
55
AMBA alert for Jun 26
Ambarella [AMBA] is up 4.36% over the past day.
Buy
54
EXOD alert for Jun 26
Exodus Movement [EXOD] is down 9.63% over the past day.
Buy
78
SMR alert for Jun 25
NuScale Power [SMR] is down 10.59% over the past day.
